Title | Type | SJR | H index | Total Docs. (2004) | Total Docs. (3years) | Total Refs. (2004) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2004) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Reviews in Contemporary Pharmacotherapy | journal | 0.557 Q2 | 18 | 1 | 11 | 854 | 16 | 11 | 1.40 | 854.00 | |
2 | Progress in Medicinal Chemistry | journal | 1.638 Q1 | 38 | 7 | 27 | 1827 | 95 | 23 | 2.79 | 261.00 | |
3 | Critical Reviews in Toxicology | journal | 1.004 Q1 | 129 | 13 | 72 | 2428 | 229 | 71 | 3.89 | 186.77 | |
4 | Natural Product Reports | journal | 2.451 Q1 | 211 | 46 | 120 | 7652 | 855 | 118 | 7.01 | 166.35 | |
5 | Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach | book series | 2 | 17 | 0 | 2762 | 0 | 0 | 0.00 | 162.47 | ||
6 | Handbook of Experimental Pharmacology | journal | 110 | 1 | 0 | 151 | 0 | 0 | 0.00 | 151.00 | ||
7 | Current Drug Metabolism | journal | 1.612 Q1 | 122 | 43 | 105 | 6141 | 492 | 99 | 4.74 | 142.81 | |
8 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.910 Q1 | 70 | 14 | 32 | 1993 | 245 | 32 | 8.04 | 142.36 | |
9 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.216 Q4 | 50 | 17 | 29 | 2216 | 24 | 29 | 3.00 | 130.35 | |
10 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.068 Q1 | 99 | 18 | 32 | 2144 | 94 | 31 | 3.09 | 119.11 | |
11 | Expert Opinion on Emerging Drugs | journal | 0.389 Q3 | 54 | 25 | 86 | 2887 | 110 | 83 | 1.37 | 115.48 | |
12 | Current Pharmacogenomics | journal | 12 | 32 | 0 | 3660 | 0 | 0 | 0.00 | 114.38 | ||
13 | Handbook of Analytical Separations | book series | 0.156 Q3 | 13 | 14 | 27 | 1587 | 9 | 10 | 0.33 | 113.36 | |
14 | American Journal of Drug Delivery | journal | 23 | 20 | 0 | 1951 | 0 | 0 | 0.00 | 97.55 | ||
15 | BioDrugs | journal | 0.737 Q2 | 79 | 35 | 172 | 3364 | 468 | 167 | 2.25 | 96.11 | |
16 | Current Drug Targets: Inflammation and Allergy | journal | 0.856 Q2 | 53 | 57 | 53 | 5459 | 143 | 53 | 2.70 | 95.77 | |
17 | Expert Opinion on Therapeutic Targets | journal | 0.930 Q1 | 106 | 54 | 162 | 4953 | 365 | 155 | 2.60 | 91.72 | |
18 | Cellular and Molecular Life Sciences | journal | 3.027 Q1 | 261 | 275 | 615 | 23250 | 3400 | 606 | 5.09 | 84.55 | |
19 | Clinical Pharmacokinetics | journal | 1.578 Q1 | 184 | 73 | 250 | 6098 | 1586 | 246 | 6.53 | 83.53 | |
20 | Neurotherapeutics | journal | 136 | 51 | 0 | 4216 | 0 | 0 | 0.00 | 82.67 | ||
21 | Expert Opinion on Investigational Drugs | journal | 1.078 Q1 | 117 | 136 | 644 | 11132 | 2222 | 621 | 4.21 | 81.85 | |
22 | Expert Opinion on Drug Delivery | journal | 133 | 16 | 0 | 1304 | 0 | 0 | 0.00 | 81.50 | ||
23 | Advanced Drug Delivery Reviews | journal | 2.753 Q1 | 366 | 119 | 379 | 9608 | 3219 | 337 | 7.88 | 80.74 | |
24 | Expert Opinion on Biological Therapy | journal | 0.928 Q1 | 102 | 170 | 292 | 13679 | 799 | 280 | 2.59 | 80.46 | |
25 | Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents | journal | 11 | 36 | 0 | 2776 | 0 | 0 | 0.00 | 77.11 | ||
26 | Toxicological Reviews | journal | 0.283 Q3 | 49 | 23 | 23 | 1767 | 22 | 22 | 0.96 | 76.83 | |
27 | Toxin Reviews | journal | 0.267 Q3 | 54 | 23 | 78 | 1684 | 55 | 69 | 0.59 | 73.22 | |
28 | Expert Opinion on Pharmacotherapy | journal | 0.535 Q2 | 93 | 230 | 532 | 15724 | 1093 | 516 | 2.00 | 68.37 | |
29 | Drug Safety | journal | 1.211 Q1 | 140 | 94 | 264 | 6299 | 1152 | 253 | 4.12 | 67.01 | |
30 | Current Pharmaceutical Biotechnology | journal | 0.790 Q1 | 97 | 62 | 94 | 4150 | 238 | 87 | 2.62 | 66.94 | |
31 | Side Effects of Drugs Annual | book series | 0.101 Q4 | 9 | 51 | 155 | 3205 | 2 | 155 | 0.01 | 62.84 | |
32 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.292 Q3 | 56 | 75 | 291 | 4638 | 250 | 290 | 0.92 | 61.84 | |
33 | Drugs of Today | journal | 0.335 Q3 | 57 | 79 | 277 | 4860 | 347 | 276 | 1.52 | 61.52 | |
34 | Journal of Drug Evaluation | journal | 0.116 Q4 | 5 | 24 | 21 | 1440 | 1 | 9 | 0.05 | 60.00 | |
35 | Journal of Molecular Medicine | journal | 2.049 Q1 | 157 | 97 | 327 | 5520 | 1277 | 297 | 3.76 | 56.91 | |
36 | Apoptosis : an international journal on programmed cell death | journal | 2.441 Q1 | 128 | 84 | 172 | 4678 | 849 | 170 | 4.74 | 55.69 | |
37 | Current Opinion in Drug Discovery and Development | journal | 1.182 Q1 | 85 | 78 | 269 | 4338 | 911 | 252 | 3.77 | 55.62 | |
38 | Neuropsychopharmacology | journal | 2.241 Q1 | 249 | 250 | 659 | 13878 | 3291 | 620 | 4.75 | 55.51 | |
39 | Molecular Diagnosis and Therapy | journal | 68 | 68 | 170 | 3725 | 393 | 167 | 2.68 | 54.78 | ||
40 | Expert Review of Vaccines | journal | 0.642 Q2 | 105 | 105 | 135 | 5673 | 275 | 125 | 2.04 | 54.03 | |
41 | Expert Opinion on Therapeutic Patents | journal | 0.488 Q2 | 88 | 117 | 383 | 6244 | 521 | 375 | 1.42 | 53.37 | |
42 | Current Opinion in Molecular Therapeutics | journal | 1.175 Q1 | 67 | 87 | 263 | 4579 | 816 | 240 | 3.20 | 52.63 | |
43 | Psychopharmacology | journal | 1.798 Q1 | 214 | 370 | 997 | 18890 | 4002 | 948 | 3.64 | 51.05 | |
44 | NeuroToxicology | journal | 0.872 Q2 | 133 | 99 | 242 | 5035 | 596 | 241 | 2.67 | 50.86 | |
45 | Neuropharmacology | journal | 1.901 Q1 | 191 | 261 | 696 | 13239 | 2861 | 696 | 4.03 | 50.72 | |
46 | Drug News and Perspectives | journal | 0.465 Q2 | 53 | 81 | 218 | 4026 | 259 | 218 | 1.34 | 49.70 | |
47 | Current Opinion in Pharmacology | journal | 2.009 Q1 | 148 | 100 | 307 | 4894 | 1450 | 282 | 4.93 | 48.94 | |
48 | Current Opinion in Investigational Drugs | journal | 0.780 Q2 | 83 | 158 | 449 | 7594 | 1156 | 418 | 2.66 | 48.06 | |
49 | Pharmacogenomics | journal | 0.933 Q1 | 100 | 98 | 219 | 4704 | 572 | 188 | 2.56 | 48.00 | |
50 | Trends in Pharmacological Sciences | journal | 3.825 Q1 | 244 | 117 | 489 | 5609 | 3267 | 392 | 7.46 | 47.94 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®